Related Experiment Video
Updated: Aug 22, 2025
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
Bridging the Scientific Gaps to Identify Effective Treatments in Adrenocortical Cancer
Nicholas Michael1, Naris Nilubol1
1Surgical Oncology Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Abstract:
Adrenocortical cancer (ACC) typically presents in advanced stages of disease and has a dismal prognosis. One of the foremost reasons for this is the lack of available systemic therapies, with mitotane remaining the backbone of treatment since its discovery in the 1960s, despite underwhelming efficacy. Surgery remains the only potentially curative option, but about half of patients will recur post-operatively, often with metastatic disease. Other local treatment options have been attempted but are only used practically on a case-by-case basis. Over the past few decades there have been significant advances in understanding the molecular background of ACC, but this has not yet translated to better treatment options. Attempts at novel treatment strategies have not provided significant clinical benefit. This paper reviews our current treatment options and molecular understanding of ACC and the reasons why a successful treatment has remained elusive. Additionally, we discuss the knowledge gaps that need to be overcome to bring us closer to successful treatment and ways to bridge them.
Insights
Adrenocortical cancer (ACC) treatment remains challenging due to limited systemic therapies and high recurrence rates. This review explores current options, molecular insights, and knowledge gaps for improving ACC outcomes.
Area of Science:
- Oncology
- Endocrinology
Background:
- Adrenocortical cancer (ACC) presents late with poor prognosis.
- Current systemic therapies, like mitotane, show limited efficacy.
- Surgery offers the only curative potential, yet recurrence is common.
Purpose of the Study:
- To review current adrenocortical cancer treatment options.
- To discuss the molecular understanding of ACC.
- To identify knowledge gaps hindering effective treatment development.
Main Methods:
- Literature review of existing treatment strategies for ACC.
- Analysis of molecular advancements in ACC research.
- Discussion of challenges and future directions in ACC therapy.
Main Results:
- Limited efficacy of current systemic treatments for advanced ACC.
- Significant molecular understanding gained, but not yet translated into improved therapies.
- High rates of post-operative recurrence and metastatic disease.
Conclusions:
- Developing effective systemic treatments for adrenocortical cancer remains a critical unmet need.
- Bridging the gap between molecular insights and clinical application is essential.
- Further research is required to overcome current therapeutic limitations and improve patient outcomes.
More Related Videos
12:55Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
Published on: February 16, 2015
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
Related Concept Videos
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
02:56Treatment Resistant Cancers
01:27Tumor Immunotherapy
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:27Adrenal Gland Disorders
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...